title: Hypertension studies in China.
abstract: In China, hypertension (HT) prevalence increased from 7.7% in 1980 to over 11% in 1991. The higher prevalence of HT in the north and among urban populations may be due in part to higher body mass index (BMI) levels and dietary composition. Community control of HT has been organized since 1969. Reports from centers with a history of community control for over 10 years have indicated a 40% and 34% decrease respectively in the incidence of stroke and acute myocardial infarction (AMI). Sino-Monica Beijing Project shows that morbidity and mortality of stroke and coronary heart disease are higher in north China and urban centers, stroke is 4-8 times higher than coronary events. The trend from 1985-1989 was relatively steady. Although the mortality of stroke and AMI was decreasing, the case fatality rate remained high, and the rapid increase in the proportion of older population points to an urgent need for a nationwide prevention and control program.
authors.affiliation: Department of Hypertension, Cardiovascular Institute, Beijing, P.R.C.
authors.forename: L
authors.initials: L
authors.lastname: Liu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D002681:China; D002986:Clinical Trials as Topic; D003153:Community Health Services; D004812:Epidemiologic Methods; D005260:Female; D006306:Health Surveys; D006801:Humans; D006973:Hypertension / Q000453:epidemiology* / Q000401:mortality / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D015995:Prevalence; D011315:Preventive Medicine / Q000379:methods; D012307:Risk Factors; D016019:Survival Analysis
chemical_list: D000959:Antihypertensive Agents